Formulary Rules Changed in 2008
The passage of SB 1062 as proposed by Nurse Practitioners of Oregon directed the State Board of Nursing to remove from rule the requirement for a specific prescribing formulary based on Drug Facts and Comparisons. The new rules removed these references and replaced sections with general prescribing principles to be included in Division 56.
The Board directed that:
- FDA approval be retained as a requirement for prescribing
- Exceptions to FDA approval be added to include expanded access and IRB authorized clinical trials
- General exceptions based upon federal prohibitions be referenced but not exhaustively listed
- Orphan drugs should be listed as specifically permitted for prescribing
The full rules of NP prescribing authority in Oregon can be found at: http://www.oregon.gov/OSBN/
Tamper Proof Prescriptions
The Oregon State Board of Pharmacy has published new criteria which defines "tamper proofâ prescriptions for the purpose of new federal regulations. The state of Oregon does not define a specific vendor which must be used. More information regarding this issue may be found at: http://www.oregon.gov/Pharmacy/TamperProofRx.shtml.
Continuing Education and Pain Management CE
The Board continues to receive many inquiries regarding the one time pain management CE requirement for all nurses as well as the CNS and NP specific continuing education requirements for renewal. Links to the Board's information regarding pain management CE may be found at: http://www.oregon.gov/OSBN/pain_management.shtml
Links to a form which may be used to track CE for Nurse Practitioners and Clinical Nurse Specialists may be located at: http://www.oregon.gov/OSBN/advanced_practice_FAQs.shtml
Free Prescribing Reference Available to NPs
The Nurse Practitioner Prescribing Reference, a quarterly publication, is an up-to-date guide to commonly prescribed pharmaceuticals, as well as certain over-the-counter products. It provides an easily accessible reminder of basic information useful to review when prescribing medications, such as specific indications for use, dosage and a checklist of precautions, interactions and adverse drug reactions. Contact 1-617-923-8519 to request an application for a free subscription if you don't already receive this booklet.